Dopamine and schizophrenia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 1976-11, Vol.2 (7995), p.1142
Hauptverfasser:	Meltzer, H Y, Goode, D J, Fang, V S, Schyve, P, Young, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Apomorphine - pharmacology Dyskinesia, Drug-Induced Humans Receptors, Dopamine - drug effects Schizophrenia - complications Schizophrenia - drug therapy Tranquilizing Agents - adverse effects Tranquilizing Agents - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	7995
container_start_page	1142
container_title	The Lancet (British edition)
container_volume	2
creator	Meltzer, H Y Goode, D J Fang, V S Schyve, P Young, M
description
doi_str_mv	10.1016/S0140-6736(76)91105-3
format	Article
fullrecord	<record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_62982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>62982</sourcerecordid><originalsourceid>FETCH-LOGICAL-p204t-a6d73d2aefef8b41092f42822f120c52aaa74611f1538b10e8cf3104072e13c03</originalsourceid><addsrcrecordid>eNo9jk1Lw0AQQOdg0Vr7BxShRz1snZnd7G6O0toPKHjQnssk2aURky6JHuyvF7T09OAdHg_gnnBKSPbpDcmgsk7bB2cfcyLMlL6A4VlfwXXffyCisZhdwsBy7nkIt_NDkqZuw0TaatKX-_p4SPsutLXcwCDKZx_GJ45gu3h5n63U5nW5nj1vVGI0X0ps5XTFEmKIvjCEOUfDnjkSY5mxiDhjiSJl2heEwZdRExp0HEiXqEdw999N30UTql3q6ka6n93fof4FAos6Kg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Dopamine and schizophrenia</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Meltzer, H Y ; Goode, D J ; Fang, V S ; Schyve, P ; Young, M</creator><creatorcontrib>Meltzer, H Y ; Goode, D J ; Fang, V S ; Schyve, P ; Young, M</creatorcontrib><identifier>ISSN: 0140-6736</identifier><identifier>DOI: 10.1016/S0140-6736(76)91105-3</identifier><identifier>PMID: 62982</identifier><language>eng</language><publisher>England</publisher><subject>Apomorphine - pharmacology ; Dyskinesia, Drug-Induced ; Humans ; Receptors, Dopamine - drug effects ; Schizophrenia - complications ; Schizophrenia - drug therapy ; Tranquilizing Agents - adverse effects ; Tranquilizing Agents - therapeutic use</subject><ispartof>The Lancet (British edition), 1976-11, Vol.2 (7995), p.1142</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/62982$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meltzer, H Y</creatorcontrib><creatorcontrib>Goode, D J</creatorcontrib><creatorcontrib>Fang, V S</creatorcontrib><creatorcontrib>Schyve, P</creatorcontrib><creatorcontrib>Young, M</creatorcontrib><title>Dopamine and schizophrenia</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><subject>Apomorphine - pharmacology</subject><subject>Dyskinesia, Drug-Induced</subject><subject>Humans</subject><subject>Receptors, Dopamine - drug effects</subject><subject>Schizophrenia - complications</subject><subject>Schizophrenia - drug therapy</subject><subject>Tranquilizing Agents - adverse effects</subject><subject>Tranquilizing Agents - therapeutic use</subject><issn>0140-6736</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1976</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9jk1Lw0AQQOdg0Vr7BxShRz1snZnd7G6O0toPKHjQnssk2aURky6JHuyvF7T09OAdHg_gnnBKSPbpDcmgsk7bB2cfcyLMlL6A4VlfwXXffyCisZhdwsBy7nkIt_NDkqZuw0TaatKX-_p4SPsutLXcwCDKZx_GJ45gu3h5n63U5nW5nj1vVGI0X0ps5XTFEmKIvjCEOUfDnjkSY5mxiDhjiSJl2heEwZdRExp0HEiXqEdw999N30UTql3q6ka6n93fof4FAos6Kg</recordid><startdate>19761120</startdate><enddate>19761120</enddate><creator>Meltzer, H Y</creator><creator>Goode, D J</creator><creator>Fang, V S</creator><creator>Schyve, P</creator><creator>Young, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19761120</creationdate><title>Dopamine and schizophrenia</title><author>Meltzer, H Y ; Goode, D J ; Fang, V S ; Schyve, P ; Young, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p204t-a6d73d2aefef8b41092f42822f120c52aaa74611f1538b10e8cf3104072e13c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1976</creationdate><topic>Apomorphine - pharmacology</topic><topic>Dyskinesia, Drug-Induced</topic><topic>Humans</topic><topic>Receptors, Dopamine - drug effects</topic><topic>Schizophrenia - complications</topic><topic>Schizophrenia - drug therapy</topic><topic>Tranquilizing Agents - adverse effects</topic><topic>Tranquilizing Agents - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meltzer, H Y</creatorcontrib><creatorcontrib>Goode, D J</creatorcontrib><creatorcontrib>Fang, V S</creatorcontrib><creatorcontrib>Schyve, P</creatorcontrib><creatorcontrib>Young, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meltzer, H Y</au><au>Goode, D J</au><au>Fang, V S</au><au>Schyve, P</au><au>Young, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dopamine and schizophrenia</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>1976-11-20</date><risdate>1976</risdate><volume>2</volume><issue>7995</issue><spage>1142</spage><pages>1142-</pages><issn>0140-6736</issn><cop>England</cop><pmid>62982</pmid><doi>10.1016/S0140-6736(76)91105-3</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 0140-6736
ispartof	The Lancet (British edition), 1976-11, Vol.2 (7995), p.1142
issn	0140-6736
language	eng
recordid	cdi_pubmed_primary_62982
source	MEDLINE; Access via ScienceDirect (Elsevier)
subjects	Apomorphine - pharmacology Dyskinesia, Drug-Induced Humans Receptors, Dopamine - drug effects Schizophrenia - complications Schizophrenia - drug therapy Tranquilizing Agents - adverse effects Tranquilizing Agents - therapeutic use
title	Dopamine and schizophrenia
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T11%3A59%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dopamine%20and%20schizophrenia&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Meltzer,%20H%20Y&rft.date=1976-11-20&rft.volume=2&rft.issue=7995&rft.spage=1142&rft.pages=1142-&rft.issn=0140-6736&rft_id=info:doi/10.1016/S0140-6736(76)91105-3&rft_dat=%3Cpubmed%3E62982%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/62982&rfr_iscdi=true